When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis
Aresta et al • 2021 • Endocr Pract.
© 2024 Corcept Therapeutics, Incorporated
About jeremiah@devisedesigns.com
This author has not written his bio yet.
But we are proud to say that jeremiah@devisedesigns.com contributed 143 entries already.
Entries by jeremiah@devisedesigns.com
Hidden hypercortisolism: a too frequently neglected clinical condition
Giovanelli et al • 2021 • J Endocrinol Invest.
Miricorilant, a selective GR modulator, induced a rapid and significant reduction in liver fat content in a randomized, placebo-controlled phase 2a study in patients with nonalcoholic steatohepatitis
Kowdley et al • 2021 • The Liver Meeting 2021 (American Association for the Study of Liver Diseases)
Relacorilant, A Selective Glucocorticoid Receptor Modulator, In Combination With Nab-Paclitaxel Improves Progression-Free Survival In Patients With Recurrent Platinum-Resistant Ovarian Cancer: A 3-Arm, Randomized, Open-Label, Phase 2 Study
Lorusso et al. • 2021 • European Society for Medical Oncology (ESMO) Congress 2021
Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
Greenstein et al. • 2021 • Oncotarget . 2021 Jun 22;12(13):1243-1255. doi: 10.18632/oncotarget.27989.
Adrenal tumors provide insight into the role of cortisol in NK cell activity
Greenstein et al. • 2021 • Endocr Relat Cancer . 2021 Jun 29;28(8):583-592. doi: 10.1530/ERC-21-0048.
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study
Hunt et al • 2021 • Journal of Clinical Psychopharmacology: August 6, 2021
Prevalence of Hypercortisolism in Patients With Adrenal Adenoma(s) and Type 2 Diabetes Mellitus: Findings From an Electronic Medical Records (EMR) Search
Isaac Sachmechi, MD, FACE, FACP; Sanna Salam; Muhammad Umair, MD; Kathleen Wade Tarnowski, MSc • 2021 •
Use of Mifepristone in a Hypercortisolemic Patient With End-Stage Renal Disease on Hemodialysis
Albert W. Coo, MD, FACE; Rebecca Ray, FNP-C • 2021 •